{"disease":{"id":"digestive-system-diseases","name":"digestive system diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT04949282","title":"Spanish Series of Patients Treated With the Radionuclide Lutetium177","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Sociedad Española de Medicina Nuclear e Imagen Molecular","has_results":false},{"nct_id":"NCT03072472","title":"BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities","phase":"NA","overall_status":"COMPLETED","enrollment_count":3221,"lead_sponsor_name":"South Tyneside and Sunderland NHS Foundation Trust","has_results":false},{"nct_id":"NCT05401058","title":"Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2968,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT01964430","title":"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the \"Apact\" Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":866,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT07222800","title":"Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04977739","title":"Research on the Application and Mechanism of New Biological Probes in Biomedicine","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT02005965","title":"Low Rectal Cancer Study (MERCURY II)","phase":"","overall_status":"UNKNOWN","enrollment_count":542,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT04493632","title":"OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"OncoSil Medical Limited","has_results":false},{"nct_id":"NCT03488446","title":"Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05209568","title":"Immune Responses to Gluten","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT04084249","title":"ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":359,"lead_sponsor_name":"Claus Lindbjerg Andersen","has_results":false},{"nct_id":"NCT05251467","title":"A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Nottingham University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT05489237","title":"First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":278,"lead_sponsor_name":"IDRX, Inc., a wholly owned subsidiary of GSK, LLC","has_results":false},{"nct_id":"NCT01995942","title":"Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial","phase":"","overall_status":"UNKNOWN","enrollment_count":246,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT01037049","title":"Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":237,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT07351071","title":"Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections","phase":"NA","overall_status":"RECRUITING","enrollment_count":137,"lead_sponsor_name":"Medtronic - MITG","has_results":false},{"nct_id":"NCT03656744","title":"A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true},{"nct_id":"NCT02613403","title":"Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":94,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03646292","title":"Antidiabetic Drugs for Steatotic Liver Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT05636657","title":"Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03614039","title":"Effect of Probiotic and Smectite Gel on NAFLD","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Nazarii Kobyliak","has_results":false},{"nct_id":"NCT03535727","title":"A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT03549494","title":"Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT03559543","title":"Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT05160168","title":"A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Theseus Pharmaceuticals","has_results":true},{"nct_id":"NCT03717298","title":"Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT02909452","title":"Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT04080843","title":"Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT02897778","title":"Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT05602935","title":"Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":29,"lead_sponsor_name":"The Second Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT04518852","title":"TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT04639115","title":"A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT03543540","title":"Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"ImmusanT, Inc.","has_results":false},{"nct_id":"NCT05160077","title":"Optoacoustic Characterization of Postprandial Intestinal Blood Flow","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT06653647","title":"Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT04644315","title":"A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03678480","title":"A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}